» Authors » Daniel Bates

Daniel Bates

Explore the profile of Daniel Bates including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 5818
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salmon J, Bates D, Du Toit N, Verrills P, Yu J, Taverner M, et al.
J Pain Res . 2024 Jan; 17:293-304. PMID: 38274409
Purpose: Spinal cord stimulation (SCS) is a highly effective treatment for chronic neuropathic pain. Despite recent advances in technology, treatment gaps remain. A small SCS system with a miniaturized implantable...
2.
Richardson G, Bates D, Ross A, Liu H, Boutwell B
Dev Psychol . 2024 Jan; 60(2):306-321. PMID: 38190216
Many developmental theories have not been sufficiently evaluated using designs that control for unobserved familial confounds. Our long-term goal is to determine the causal structure underlying associations between early environmental...
3.
Vierstra J, Lazar J, Sandstrom R, Halow J, Lee K, Bates D, et al.
Nature . 2020 Jul; 583(7818):729-736. PMID: 32728250
Combinatorial binding of transcription factors to regulatory DNA underpins gene regulation in all organisms. Genetic variation in regulatory regions has been connected with diseases and diverse phenotypic traits, but it...
4.
Meuleman W, Muratov A, Rynes E, Halow J, Lee K, Bates D, et al.
Nature . 2020 Jul; 584(7820):244-251. PMID: 32728217
DNase I hypersensitive sites (DHSs) are generic markers of regulatory DNA and contain genetic variations associated with diseases and phenotypic traits. We created high-resolution maps of DHSs from 733 human...
5.
Lazar J, Stehling-Sun S, Nandakumar V, Wang H, Chee D, Howard N, et al.
Cell Rep . 2020 Jun; 31(12):107788. PMID: 32579918
No abstract available.
6.
Lazar J, Stehling-Sun S, Nandakumar V, Wang H, Chee D, Howard N, et al.
Cell Rep . 2020 May; 31(8):107676. PMID: 32460018
The human genome encodes millions of regulatory elements, of which only a small fraction are active within a given cell type. Little is known about the global impact of chromatin...
7.
Bates D, Schultheis B, Hanes M, Jolly S, Chakravarthy K, Deer T, et al.
Pain Med . 2019 Jun; 20(Suppl 1):S2-S12. PMID: 31152178
Background: The objective of this review was to merge current treatment guidelines and best practice recommendations for management of neuropathic pain into a comprehensive algorithm for primary physicians. The algorithm...
8.
Antony A, Schultheis B, Jolly S, Bates D, Hunter C, Levy R
Pain Med . 2019 Jun; 20(Suppl 1):S41-S46. PMID: 31152174
Objective: The objective of this study is to review the available evidence for dorsal root ganglion (DRG) stimulation for the treatment of complex regional pain syndrome type II (CRPS II;...
9.
Siebenthall K, Miller C, Vierstra J, Mathieu J, Tretiakova M, Reynolds A, et al.
EBioMedicine . 2019 Mar; 41:427-442. PMID: 30827930
Background: Transcriptional dysregulation drives cancer formation but the underlying mechanisms are still poorly understood. Renal cell carcinoma (RCC) is the most common malignant kidney tumor which canonically activates the hypoxia-inducible...
10.
Sieber K, Batorsky A, Siebenthall K, Hudkins K, Vierstra J, Sullivan S, et al.
J Am Soc Nephrol . 2019 Feb; 30(3):421-441. PMID: 30760496
Background: Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements,...